Narrow search
Showing 1 - 10 of 179
Cover Image
Research, Innovation and Technological Performance in Germany (Report 2012)
Backes-Gellner, Uschi - 2013
On behalf of the Federal Government of Germany, the Commission of Experts for Research and Innovation presents its …
Persistent link: https://www.econbiz.de/10013082602
Cover Image
Research, Innovation and Technological Performance in Germany (Report 2010)
Achleitner, Ann‐Kristin - 2014
On behalf of the Federal Government of Germany, the Commission of Experts for Research and Innovation presents its … and innovation in Part C are presented in a new format, which we hope will be more readily accessible for decision … 2010. The German innovation system has done fairly well in the crisis. In addition, appropriate importance has been …
Persistent link: https://www.econbiz.de/10013069278
Cover Image
Research, Innovation and Technological Performance in Germany
Achleitner, Ann‐Kristin - 2014
Research and innovation are extremely important for Germany. New insights are generated by research, and new ways of … and innovation, and where the country ranks in the international innovation contest. The Federal Government of Germany … therefore decided in 2006 to establish an independent Commission of Experts on Research and Innovation (EFI), with the remit to …
Persistent link: https://www.econbiz.de/10012708751
Cover Image
Research, Innovation and Technological Performance in Germany (Report 2011)
Achleitner, Ann‐Kristin; Allmendinger, Jutta; … - 2013
On behalf of the Federal Government of Germany, the Commission of Experts for Research and Innovation presents its …
Persistent link: https://www.econbiz.de/10014185185
Cover Image
Research, Innovation and Technological Performance in Germany (Report 2013)
Backes-Gellner, Uschi; Boehringer, Christoph; … - 2013
On behalf of the Federal Government of Germany, the Commission of Experts for Research and Innovation presents its …
Persistent link: https://www.econbiz.de/10014158441
Cover Image
Research, Innovation and Technological Performance in Germany (Report 2009)
Achleitner, Ann‐Kristin; Allmendinger, Jutta; Grupp, … - 2013
On behalf of the German Federal Government, the Commission of Experts for Research and Innovation presents its second … measures to further strengthen the innovation potential of Germany. In particular in the present economic diffi culties …, research and innovation policies have a central role to play. The challenges faced are varied and were already named in the EFI …
Persistent link: https://www.econbiz.de/10014206572
Cover Image
The power of individual-level drivers of inventive performance
Zwick, Thomas; Frosch, Katharina; Hoisl, Karin; … - 2015
Based on an established theoretical framework of the drivers of inventive performance, the so-called KSAO (Knowledge, Skills, Abilities, and Other) factors, this paper seeks to explain empirically the performance of inventors throughout their careers. We combine survey information spanning the...
Persistent link: https://www.econbiz.de/10011381965
Cover Image
Institutionalized incentives for ingenuity : patent value and the German Employees' Inventions Act
Harhoff, Dietmar; Hoisl, Karin - 2006
Germany is one of few countries in which the monetary compensation for inventors is not only determined by negotiations between employer and employee-inventor, but also by relatively precise legal provisions. In this paper, we describe the characteristics of the German Employees' Inventions Act...
Persistent link: https://www.econbiz.de/10010441538
Cover Image
Have newer cardiovascular drugs reduced hospitalization? : evidence from longitudinal country-level data on 20 OECD countries, 1995 - 2003
Lichtenberg, Frank R. - In: Health economics 18 (2009) 5, pp. 519-534
Persistent link: https://www.econbiz.de/10003845298
Cover Image
Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence from Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003
Lichtenberg, Frank R. - 2010
This study examines the effect of changes in the vintage distribution of cardiovascular system drugs on hospitalization and mortality due to cardiovascular disease using longitudinal country-level data. The vintage of a drug is the first year in which it was marketed anywhere in the world. We...
Persistent link: https://www.econbiz.de/10012759312